Lowell Therapeutics, Inc — Form D
Lowell Therapeutics, Inc of LOWELL, MA, a company, filed a Form D exempt-offering notice with the SEC on 2021-10-04. The offering totals $7.0M, of which $3.8M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2021-10-04
- Form: D
- Accession: 0001885582-21-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $7.0M
- Amount sold: $3.8M
- Remaining: $3.2M
- Investors: 7
- Date of first sale: 2021-09-20
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-415500
Issuer
- Name: Lowell Therapeutics, Inc
- CIK: 0001885582
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 110 CANAL STREET, LOWELL, MA, 01852
- Phone: (978) 649-4841
Officers, directors & promoters (2)
| Name | Role | Location |
|---|
| James Wilkie | Director | Birmingham, AL |
| James Wilkie | Executive Officer | Birmingham, AL |
Other filings by this issuer (2)
More